The Billion-Dollar Question: Medicare’s New GLP-1 Bridge Program Faces Fiscal Scrutiny on July 1, 2026 Posted by
Empowering the Future of Fitness: An Exclusive Invitation to the July IDEA Member Meet-Up on July 1, 2026 Posted by
Breaking the Barrier: New Protein Discovery Promises to Supercharge CAR T-Cell Cancer Therapy on July 1, 2026 Posted by
The Metabolic Mind: Unraveling the Intricate Link Between Diabetes and Dementia on July 1, 2026 Posted by
Ipsen Accelerates Rare Disease Strategy with Strategic Acquisition of Memo Therapeutics on July 1, 2026 Posted by
Shaping the Future of Respiratory Medicine: The ERS Leadership Elections 2026 on July 1, 2026 Posted by
The Billion-Dollar Question: Medicare’s New GLP-1 Bridge Program Faces Fiscal Scrutiny on July 1, 2026 Posted by
Empowering the Future of Fitness: An Exclusive Invitation to the July IDEA Member Meet-Up on July 1, 2026 Posted by
Breaking the Barrier: New Protein Discovery Promises to Supercharge CAR T-Cell Cancer Therapy on July 1, 2026 Posted by
Posted in Sleep Health Strategic Expansion: Eli Lilly Finalizes Acquisition of Centessa Pharmaceuticals to Bolster Neuroscience Pipeline on June 25, 2026
Posted in Sleep Health Breakthrough in Cardiometabolic Medicine: Eli Lilly’s Retatrutide Shows Dual Efficacy Against Obesity and Sleep Apnea on June 23, 2026
Posted in Digital Health Tools The 340B Standoff: Eli Lilly’s Enforcement Action Ignites Industry-Wide Conflict on June 23, 2026
Posted in Digital Health Tools A New Frontier in Myelofibrosis: Eli Lilly’s Novel JAK2 Inhibitor Shows Promise in Early Trials on June 21, 2026
Posted in Medical Innovations The 340B Stand-off: Eli Lilly Initiates Retaliatory Measures Against Hospitals Over Claims Data on June 19, 2026
Posted in Medical Innovations Eli Lilly Doubles Down on Non-Opioid Innovation with 4E Therapeutics Acquisition on June 16, 2026
Posted in Medical Innovations Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Market Dominance Following Strong Phase 1 Data on June 16, 2026
Posted in Digital Health Tools Abridge Accelerates AI Integration: Strategic Alliances with Nvidia and Eli Lilly Signal New Era in Clinical Intelligence on June 14, 2026
Posted in Digital Health Tools Biotech Markets in Flux: Legend Biotech’s Surge, Lilly’s Expansion, and the Shifting Regulatory Landscape on June 4, 2026 rifanmuazin
Posted in Medical Innovations Eli Lilly Doubles Down on Genetic Medicine: A $1.9 Billion Bet on Ascidian’s RNA Exon Editing on June 3, 2026 rifanmuazin
